Ashnoor Textile Mills Limited, established in January 1984, specializes in the production and export of high-quality terry towels. The company's core business revolves around towel manufacturing, including colored varieties, tailored to market needs. Operating solely in India, the company functions as a single entity with a focus on its primary business.
By June 30, 2023, the company had produced over 845 tons of terry towels.
Ashnoor Textile Mills holds ISO 9001 and 14001 certifications and exports its terry towels to the United States.
As of June 30, 2023, the company employs 296 staff members across its operations.
Ashnoor Textile Mills Ltd is offering an Issue size of Rs 6.37 Crores. The subscription for this Right Issue will be open from May 7, 2024, to May 16, 2024. For every fully paid-up equity share held on the record date of March 26, 2024, shareholders are entitled to ₹1 Rights equity shares. The face value of each share is Rs. 10, with the Right Issue price set at Rs. 20 per share.
Corporate Action | |
---|---|
Security Name | Ashnoor Textile Mills Ltd |
Issue Open/Close | May 7, 2024-May 16, 2024 |
Record Date | April 26, 2024 |
Issue Size (Amount) | ₹6.37 Crores |
Issue Size (Shares) | ₹3,186,462 |
Right Issue Price | ₹20 per share |
Face Value | ₹10 Per Shares |
CMP | ₹52 |
Renunciation of Rights Entitlements | May 13, 2024 |
Terms of Payment | The Issue Price of Rs.20/- per Rights Equity Share payable on application |
Entitlement | ₹1 Rights Equity Shares for every 4 fully paid-up Equity Shares held on Record Date |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com.
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.